3B8-25291-03745
3 vaccinations
4 coded responses
23 check-ins
4 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 36-40
- ZIP prefix
- 488 / MI
- Registered
- 2021-03-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-16
Registered in v-safe
-
2021-03-16
Dose 1 — Janssen/Johnson & Johnson
- 2021-03-16
-
2021-03-17
Survey response — days 1–6 daily, dose 1MedDRA: Self-medication — Feeling: Good · Site: Pain · Fever · Chills, HeadacheFree text: These symptoms went away with sleep, and 2 200mg ibuprofenMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-18
Survey response — days 1–6 daily, dose 1MedDRA: Injection site pain — Feeling: Good · Site: PainFree text: The soreness at the injection site is nearly gone. I only feel it if I press on the injection site/deltoid muscle with my hand.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-19
Survey response — days 1–6 daily, dose 1MedDRA: Injection site injury, Tenderness — Feeling: Good · Site: PainFree text: Minimal soreness at the injection site. I only feel it if I press on the injection site with my opposite hand.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-20
- 2021-03-21
- 2021-03-23
- 2021-03-30
- 2021-04-06
- 2021-04-15
- 2021-04-21
- 2021-04-27
- 2021-06-15
- 2021-09-14
-
2021-10-23
Dose 2 — Moderna
-
2022-03-16
Survey response — 12 months, dose 1MedDRA: Influenza, Nasopharyngitis, SARS-CoV-2 test positive — Feeling: Good · Be unable to work or attend schoolFree text: I tested positive for Covid19, and had mild cold/flu symptoms for about 2 weeks. This was via direct contact with another person who had also received a booster in Oct. 2021.MedDRA releases: 2024-11 · check-in free text available
-
2022-09-12
Dose 3 — ModernaCo-administered: Flu
- 2022-09-20
- 2022-09-26
- 2022-10-04
- 2022-10-10
- 2022-10-17
- 2022-10-24
- 2022-12-12
- 2023-03-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-16 | Janssen/Johnson & Johnson | |
| 2 | 2021-10-23 | Moderna | No |
| 3 | 2022-09-12 | Moderna | Flu |
Free text
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): These symptoms went away with sleep, and 2 200mg ibuprofen
Systemic reaction (other): The soreness at the injection site is nearly gone. I only feel it if I press on the injection site/deltoid muscle with my hand.
Systemic reaction (other): Minimal soreness at the injection site. I only feel it if I press on the injection site with my opposite hand.
Release 11 — 12 months, dose 1
Symptoms: I tested positive for Covid19, and had mild cold/flu symptoms for about 2 weeks. This was via direct contact with another person who had also received a booster in Oct. 2021.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Influenza | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SRO | Injection site injury | ✓ | ✓ | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | Self-medication | ✓ | ✓ | ✓ |
| SRO | Tenderness | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release